{
    "clinical_study": {
        "@rank": "1437", 
        "arm_group": [
            {
                "arm_group_label": "Universal antibiotic prophylaxis", 
                "arm_group_type": "Active Comparator", 
                "description": "In the universal prophylaxis group, all women received doxycycline 100 mg twice daily for 7 days starting on the day of induced abortion. Screening for sexually transmitted diseases was done as baseline but the results were not revealed to the patients."
            }, 
            {
                "arm_group_label": "Screen-and-treat", 
                "arm_group_type": "Active Comparator", 
                "description": "In the screen-and-treat group, the results of screening for sexually transmitted infections (STI) were revealed to the patients. They would only receive appropriate specific antibiotics treatment only if they were screened positive for any of the STIs. If they were found to have STI, their sexual partners would also be referred to the local social hygiene clinics for contact tracing and treatment. Contraception by barrier methods would also be advised."
            }
        ], 
        "brief_summary": {
            "textblock": "Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced\n      abortion, and at the same time alters women's sexual behavior and prevents further\n      re-infection by sexually transmitted infections when compared to the universal antibiotic\n      prophylaxis strategy."
        }, 
        "brief_title": "To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy", 
        "completion_date": {
            "#text": "February 2006", 
            "@type": "Actual"
        }, 
        "condition": [
            "Induced Abortion", 
            "Postaboral Pelvic Inflammatory Disease", 
            "Sexually Transmitted Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sexually Transmitted Diseases", 
                "Pelvic Inflammatory Disease", 
                "Pelvic Infection"
            ]
        }, 
        "detailed_description": {
            "textblock": "While universal antibiotic prophylaxis during induced abortion has been proven to reduce\n      postabortal pelvic inflammatory diseases, screen-and-treat approach has the potential\n      benefit of altering women's sexual behavior and preventing further re-infection by sexually\n      transmitted infections. We conducted a randomized controlled trial to compare the effect of\n      the two approaches in preventing postabortal pelvic inflammatory disease and the women's\n      sexual behavior."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women requesting for induced abortion in the gynecology clinic\n\n        Exclusion Criteria:\n\n          -  nil"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "2193", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01842100", 
            "org_study_id": "QMHRC99 - 15 RC/B/121"
        }, 
        "intervention": [
            {
                "arm_group_label": "Universal antibiotic prophylaxis", 
                "description": "100 mg twice daily for 7 days starting on the day of induced abortion", 
                "intervention_name": "Universal antibiotic prophylaxis", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Screen-and-treat", 
                "description": "Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.", 
                "intervention_name": "Screen-and-treat", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Induced abortion", 
            "Postaboral pelvic inflammatory disease", 
            "Sexually transmitted infections", 
            "Universal antibiotic prophylaxis", 
            "Screen-and-treat approach"
        ], 
        "lastchanged_date": "April 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hong Kong", 
                    "country": "China", 
                    "state": "Hong Kong"
                }, 
                "name": "Queen Mary Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy", 
        "overall_official": {
            "affiliation": "The University of Hong Kong", 
            "last_name": "Sofie SF Yung, MBBS, MRCOG", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Hong Kong:   Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2006", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Rate of postabortal inflammatory disease 6 weeks after induced abortion.", 
            "safety_issue": "No", 
            "time_frame": "6 weeks after induced abortion."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01842100"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Rate of re-infection by sexually transmitted infections 24 weeks after induced abortion.", 
                "safety_issue": "No", 
                "time_frame": "24 weeks after induced abortion."
            }, 
            {
                "measure": "Proportion of women having abstinence from sexual intercourse or using condom at 6 weeks, 24 weeks and 1 year after induced abortion.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks, 24 weeks and 1 year after induced abortion"
            }
        ], 
        "source": "The University of Hong Kong", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of Hong Kong", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 1999", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}